Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Mark Buyse"'
Autor:
Debra A. Patt, Bent Ejlertsen, Erhan Gokmen, Ira Gore, Angel Guerrero-Zotano, Alvin Wong, Mark Buyse, Tajana Silovski, Frankie A. Holmes, Arlene Chan, Hiroji Iwata, John A. Smith, Janine Mansi, Richard A. Bryce, Suzette Delaloge, Anna Bashford, Miguel Martin, Carlos H. Barrios, Neelima Denduluri, Feng Xu, Beverly Moy, Michael Gnant, Stephen Chia, Robert Šeparović
Publikováno v:
Cancer Research. 81:PD3-03
Background: Neratinib (NERLYNX®) is an irreversible pan-HER inhibitor that significantly improves invasive disease-free survival (iDFS) compared with placebo when given as extended adjuvant therapy in patients with HER2-positive (HER2+) early breast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e872c28d847e648933c8d69677bfe41
https://doi.org/10.1158/1538-7445.sabcs20-pd3-03
https://doi.org/10.1158/1538-7445.sabcs20-pd3-03
